SEC Form 4 · accession 0001178913-18-000195

Foamix Pharmaceuticals Ltd. · FOMX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Other

Period of report

Jan 2, 2018

Accepted (ET)

Jan 18, 2018 · 5:10 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001606645

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Ordinary Shares^F2	Jan 2, 2018	S	5,000	$6.1805	D	2,752,781	I	See footnote
Ordinary Shares^F2	Jan 3, 2018	S	5,000	$6.2621	D	2,747,781	I	See footnote
Ordinary Shares^F2	Jan 4, 2018	S	5,000	$6.6822	D	2,742,781	I	See footnote
Ordinary Shares^F2	Jan 5, 2018	S	5,000	$6.5763	D	2,737,781	I	See footnote
Ordinary Shares^F2	Jan 8, 2018	S	5,000	$6.17	D	2,732,781	I	See footnote
Ordinary Shares^F2	Jan 9, 2018	S	5,000	$6.104	D	2,727,781	I	See footnote
Ordinary Shares^F2	Jan 10, 2018	S	5,000	$6.0454	D	2,722,781	I	See footnote
Ordinary Shares^F2	Jan 11, 2018	S	5,000	$6.3317	D	2,717,781	I	See footnote
Ordinary Shares^F3	Jan 1, 2018	M	5,032	—	A	16,271	D
Ordinary Shares^F3	Jan 15, 2018	M	1,125	—	A	17,396	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Share Units^F3,F4	—	Jan 1, 2018	M	5,032	D	—	—	Ordinary Shares	5,032	15,098	D
Restricted Share Units^F3,F5	—	Jan 15, 2018	M	1,125	D	—	—	Ordinary Shares	1,125	4,500	D

F1These transactions were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 6, 2017
F2Shares held by Meir Eini Holdings Ltd., an Israeli company owned and controlled by the reporting person
F3The Restricted Share Units convert into Ordinary Shares on a one-for-one basis
F4The Restricted Share Units vest over a period of four years (25% on January 1, 2018 and 6.25% every three months thereafter) ending January 1, 2018
F5The Restricted Share Units vest in equal installments every three months over the vesting period ending January 15, 2019